The use of cefepime for treating AmpC β-lactamase-producing Enterobacteriaceae.

نویسندگان

  • Pranita D Tamma
  • Sonya C T Girdwood
  • Ravindra Gopaul
  • Tsigereda Tekle
  • Ava A Roberts
  • Anthony D Harris
  • Sara E Cosgrove
  • Karen C Carroll
چکیده

BACKGROUND  AmpC β-lactamase-producing organisms are associated with significant morbidity and mortality. Induction of resistance to third-generation cephalosporins after exposure to these agents complicates treatment options and carbapenems are considered optimal therapy. The role of cefepime, however, remains unclear. Our objective was to compare clinical outcomes for patients receiving cefepime compared with meropenem for invasive infections caused by organisms expressing AmpC β-lactamases. METHODS  Hospitalized patients with blood, bronchoalveolar lavage, or intra-abdominal fluid cultures growing Enterobacter spp, Serratia spp, or Citrobacter spp were evaluated using the cefotetan-boronic acid disk test and the cefotetan-cloxacillin Etest to identify organisms with AmpC β-lactamase production from February 2010 to January 2011. In patients with organisms hyperproducing AmpC β-lactamases (positive by both methods), clinical outcomes for patients receiving cefepime or meropenem therapy were compared. To minimize the possibility of treatment selection bias, 1:1 nearest neighbor propensity score matching was performed prior to regression analysis. RESULTS  Of 399 patients meeting eligibility criteria, 96 (24%) had confirmed infections with AmpC β-lactamase-producing organisms. Propensity score matching of patients infected with AmpC β-lactamase-positive organisms treated with cefepime or meropenem yielded 32 well-balanced patient pairs with no difference in 30-day mortality (odds ratio, 0.63; 95% confidence interval [CI], .23-2.11; P = .36) or length of hospital stay after infection (relative risk, 0.96; 95% CI, .79-1.26; P = .56) between the 2 groups. CONCLUSIONS  Cefepime may be a reasonable option for the treatment of invasive infections due to AmpC β-lactamase-producing organisms, particularly when adequate source control is achieved.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Study of Drug Resistance in Enterobacteriaceae Isolates

Background & objectives: Members of the family enterobacteriaceae comprise the most common gram-negative isolates in microbiology laboratories. Amongst these members, multiple antibiotic-resistant isolates including those producing extended spectrum β-lactamases (ESBL) and AmpC β-lactamases (AmpC) have increased steadily. Further, metallo-β-lactamase (MBL) producing strains are also recently de...

متن کامل

AmpC β-lactamases in nosocomial isolates of Klebsiella pneumoniae from India

BACKGROUND & OBJECTIVES AmpC β-lactamases are clinically significant since these confer resistance to cephalosporins in the oxyimino group, 7-α methoxycephalosporins and are not affected by available β-lactamase inhibitors. In this study we looked for both extended spectrum β-lactamases (ESBL) and AmpC β-lactamases in Klebsiella pneumoniae clinical isolates. METHODS One hundred consecutive, n...

متن کامل

Prevalence and antimicrobial susceptibility patterns of ESBL, AmpC and Carbapenemase- producing Enterobactericeae isolated from hospitalized patients in Azerbaijan, Iran

Current study was conducted to determine prevalence and antimicrobial susceptibility patterns, ESBL, AmpC and carbapenemase- producers among clinical isolates of Enterobacteriaceae. Three hundred and seven non-duplicative clinical isolates were collected from hospitalized patients in five medical centers in Azerbaijan, Iran. Initial screening for β-lactamase production was performed using disc ...

متن کامل

Multidrug resistant AmpC β-lactamase producing Escherichia coli isolated from a paediatric hospital

UNLABELLED Objective : The objective of the study was to observe the antimicrobial resistance of AmpC β-lactamase producing E. coli. METHODS Six hundred and seventy E. coli were isolated from 20,257 various pathological samples collected from The Children's Hospital and Institute of Child Health, Lahore, Pakistan. The isolates showed resistance to ceftazidime which were further examined for A...

متن کامل

Prevalence and antimicrobial susceptibility patterns of ESBL, AmpC and Carbapenemase- producing Enterobactericeae isolated from hospitalized patients in Azerbaijan, Iran

Current study was conducted to determine prevalence and antimicrobial susceptibility patterns, ESBL, AmpC and carbapenemase- producers among clinical isolates of Enterobacteriaceae. Three hundred and seven non-duplicative clinical isolates were collected from hospitalized patients in five medical centers in Azerbaijan, Iran. Initial screening for β-lactamase production was performed using disc ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

دوره 57 6  شماره 

صفحات  -

تاریخ انتشار 2013